NeoGenomics, Inc. Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill)
NeoGenomics, Inc. (NEO) reported Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill) of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-17.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill · last filed 2026-02-17
- NeoGenomics, Inc. impairment of intangible assets, indefinite-lived (excluding goodwill) for fiscal 2025 was $0.00.
- NeoGenomics, Inc. impairment of intangible assets, indefinite-lived (excluding goodwill) for fiscal 2024 was $0.00.
- NeoGenomics, Inc. impairment of intangible assets, indefinite-lived (excluding goodwill) for fiscal 2023 was $0.00.
- NeoGenomics, Inc. impairment of intangible assets, indefinite-lived (excluding goodwill) for fiscal 2022 was $0.00.
| Period end | Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill) 12 month |
|---|---|
| 2025-12-31 | $0.00 10-K · filed 2026-02-17 |
| 2024-12-31 | $0.00 10-K · filed 2026-02-17 |
| 2023-12-31 | $0.00 10-K · filed 2026-02-17 |
| 2022-12-31 | $0.00 10-K · filed 2025-02-18 |
| 2021-12-31 | $0.00 10-K · filed 2024-02-20 |
| 2020-12-31 | $0.00 10-K · filed 2023-02-24 |
| 2019-12-31 | $0.00 10-K · filed 2022-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 20/20 Biolabs, Inc. (AIDX) | United States | $0.005B |